Literature DB >> 25668491

Exome sequencing identifies SUCO mutations in mesial temporal lobe epilepsy.

Zhiqiang Sha1, Longze Sha1, Wenting Li1, Wanchen Dou2, Yan Shen1, Liwen Wu3, Qi Xu4.   

Abstract

Mesial temporal lobe epilepsy (mTLE) is the main type and most common medically intractable form of epilepsy. Severity of disease-based stratified samples may help identify new disease-associated mutant genes. We analyzed mRNA expression profiles from patient hippocampal tissue. Three of the seven patients had severe mTLE with generalized-onset convulsions and consciousness loss that occurred over many years. We found that compared with other groups, patients with severe mTLE were classified into a distinct group. Whole-exome sequencing and Sanger sequencing validation in all seven patients identified three novel SUN domain-containing ossification factor (SUCO) mutations in severely affected patients. Furthermore, SUCO knock down significantly reduced dendritic length in vitro. Our results indicate that mTLE defects may affect neuronal development, and suggest that neurons have abnormal development due to lack of SUCO, which may be a generalized-onset epilepsy-related gene.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dendritic formation; Mesial temporal lobe epilepsy; Whole-exome sequencing

Mesh:

Substances:

Year:  2015        PMID: 25668491     DOI: 10.1016/j.neulet.2015.02.009

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  SUCO as a Promising Diagnostic Biomarker of Hepatocellular Carcinoma: Integrated Analysis and Experimental Validation.

Authors:  Chaosen Yue; Chaojie Liang; Hua Ge; Lijun Yan; Yingchen Xu; Guangming Li; Jixiang Wu
Journal:  Med Sci Monit       Date:  2019-08-22

2.  Decreased Expression of circ_0000160 in Breast Cancer With Axillary Lymph Node Metastasis.

Authors:  Ya-Wen Wang; Xu Chen; Yaru Tian; Long Liu; Peng Su
Journal:  Front Mol Biosci       Date:  2022-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.